CERTIFICATE OF ANALYSISCS0897_202182-003_C
Client Sample ID: 200131TNFL500c PureEVIE
1204 Village Market Pl #226
Morrisville, NC 27560
Receive sample: 31-Jan-20
Initiate analyses: 03-Feb-20
Analyst: Signature: Date:
Reviewed by: Signature: Date:
Test Type: Total Cannabinoid Profile
Technical Procedure: TP A0033 & A0049
Results:
Chemical
Analyzed% Weight
Concentration
(mg/g)
CBN <0.01 <0.10
Δ9 THC 0.08 0.76
CBDV <0.01 <0.10 C:\Users\Dave Minser\Google Drive\02 Avazyme Controlled Substances\Pictures\2020\202182-003.jpg
CBG 0.03 0.31
CBD 2.00 20.02
CBC 0.11 1.06
CBDA 0.19 1.93
CBGA <0.01 <0.10
THCA <0.01 <0.10
THCV <0.01 <0.10
* total THC 0.08 0.76
* total CBD 2.17 21.71
total 2.42 24.16
28.6
* total THC is calculated by Δ9 THC + 0.877xTHCA
* total CBD is calculated by CBD + 0.877xCBDA
Cannabinoids
Concentration of cannabinoids were determined by Shimadzu LC2030 Plus with an Avazyme intra lab validated method utilizing certified reference standards for
each chemical analyzed.
The result applies only to the sample listed on this certificate. Avazyme cannot guarantee that this sample is representative of the product/lot as a whole.
Avazyme warrants that this study was performed in accordance with appropriate laboratory research practices and protocols for the sample submitted.
Avazyme is not responsible for Sponsor's use of the information or concepts generated as part of the study, and will not be liable for any loss or damage resulting
from such use.
Dave Minser
Jacob Edwards
Sample Description: PureFULL 500 mg + organic cinnamon
ratio: Total CBD/THC
<0.0
1
0.0
8
<0.0
1
0.0
3
2.0
0
0.1
1
0.1
9
<0.0
1
<0.0
1
<0.0
1
C B N Δ 9 T H C C B D V C B G C B D C B C C B D A C B G A T H C A T H C V
WEI
GH
T P
ERC
ENT
CHEMICAL
Avazyme, Inc. 2202 Ellis Rd Suite A, Durham, NC 27703 www.avazyme.com Page 1 of 1
DocuSign Envelope ID: CA88EBCF-D387-4240-8A0A-E1208174992D
04-Feb-2020 | 17:32 EST
05-Feb-2020 | 13:19 EST
